ArticlemedRxiv : the preprint server for health sciences2024
Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell Carcinoma.
Yuta Asano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.